
Neurobit is a leading medical technology company that develops Software as a Medical Device (SaMD) powered by AI to decipher intricate patterns in health vitals measured during sleep, termed 'sleep biomarkers'. This technology aids in delivering tailored, predictive, and precision healthcare. With a vision to establish a universally accessible health analytics system, Neurobit aims to enhance care quality and efficiency for healthcare professionals and patients. Our Biomarker Bridge initiative is at the forefront of this mission—creating a collaborative platform that connects AI-driven biomarker companies, enabling cross-disciplinary innovation, and accelerating the integration of digital biomarkers into clinical practice. Globally, over 150 esteemed universities, hospitals, and R&D centers rely on our advanced technology solutions to push the boundaries of healthcare innovation.

Neurobit is a leading medical technology company that develops Software as a Medical Device (SaMD) powered by AI to decipher intricate patterns in health vitals measured during sleep, termed 'sleep biomarkers'. This technology aids in delivering tailored, predictive, and precision healthcare. With a vision to establish a universally accessible health analytics system, Neurobit aims to enhance care quality and efficiency for healthcare professionals and patients. Our Biomarker Bridge initiative is at the forefront of this mission—creating a collaborative platform that connects AI-driven biomarker companies, enabling cross-disciplinary innovation, and accelerating the integration of digital biomarkers into clinical practice. Globally, over 150 esteemed universities, hospitals, and R&D centers rely on our advanced technology solutions to push the boundaries of healthcare innovation.
What they do: AI-driven Software as a Medical Device for sleep-derived biomarkers and health analytics
Products: Neurobit PSG, Neurobit Score, Neurobit HUB, Neurobit Zen
Headquarters / presence: Headquartered in New York; additional presence in Bangalore and Singapore
Team size (reported): 7 employees
Latest disclosed funding: Seed round on 2023-04-01; total reported funding $1,590,000 (USD)
Sleep-derived biomarkers and health analytics for healthcare providers, researchers, and enterprises.
Medical technology; digital health
Latest disclosed funding event listed as a Seed round on 2023-04-01
“Reported investors include iHealthtech, National University of Singapore (NUS), and Enterprise Singapore; company has announced active fundraising (bridge round via RUV and a crowdfunding round scheduled to close 2024-03-31)”